The effects of the proton pump inhibitor esomeprazole alone or in combination with Coca-Cola on the absorption of Capecitabine in patients with colorectal cancer (' the COCA study' Het effect van de protonpompremmeresomeprazol op de absorptie van capecitabine bij patiËnten met colorectaal carcinomen 'de COCA study')

Next Previous
Trial Profile

The effects of the proton pump inhibitor esomeprazole alone or in combination with Coca-Cola on the absorption of Capecitabine in patients with colorectal cancer (' the COCA study' Het effect van de protonpompremmeresomeprazol op de absorptie van capecitabine bij patiËnten met colorectaal carcinomen 'de COCA study')

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Mar 2018

At a glance

  • Drugs Capecitabine (Primary) ; Esomeprazole (Primary)
  • Indications Colorectal cancer
  • Focus Pharmacokinetics
  • Acronyms COCA-study

    • Most Recent Events

    • 06 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top